Literature DB >> 32737724

Hemostimulating Effects of c-Jun N-Terminal Kinase (JNK) Inhibitor during Cytostatic Myelosuppression and Mechanisms of Their Development.

G N Zyuz'kov1, V V Zhdanov2, L A Miroshnichenko2, E V Simanina2, T Yu Polyakova2, L A Stavrova2, V I Agafonov2, M Yu Minakova2, M G Danilets2, A A Ligacheva2.   

Abstract

The hemostimulating effects of c-Jun N-terminal kinase (JNK) inhibitor were examined on the mouse model of myelosuppression provoked by 5-fluorouracil. Blockade of JNK during postcytostatic period accelerated recovery of granulomonocytopoiesis and erythropoiesis. It also increased the content of neutrophilic granulocytes and erythroid cells in the hematopoietic tissue and elevated the counts of neutrophils and reticulocytes in the peripheral blood. The development of these phenomena resulted from elevated content and up-regulated functional activity of bone marrow hematopoietic progenitors associated with the direct action of JNK inhibitor on these progenitors and enhanced secretion of hemopoietins by stromal elements of the hematopoiesis-inducing microenvironment.

Entities:  

Keywords:  JNK; cytostatic myelosuppression; hematopoietic progenitor cells; signal transduction; targeted hemostimulators

Mesh:

Substances:

Year:  2020        PMID: 32737724     DOI: 10.1007/s10517-020-04880-z

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  2 in total

1.  Erythropoesis-Stimulating Properties of Anthocyanin-Containing Complexes in Cytostatic Anemic Syndrome.

Authors:  O Yu Rybalkina; E P Fedorova; A V Chaikovskii; T G Razina; G I Kalinkina; N V Isaikina; E A Kiseleva; G N Zyuz'kov; E P Zueva
Journal:  Bull Exp Biol Med       Date:  2021-04-24       Impact factor: 0.804

2.  Role of JNK and p53 in Implementation of Functions of Various Types of Regeneration-Competent Cells of the Nervous Tissue.

Authors:  G N Zyuz'kov; V V Zhdanov; L A Miroshnichenko; T Yu Polyakova; E V Simanina; L A Stavrova; M G Danilets; V I Agafonov; A V Chaikovskii
Journal:  Bull Exp Biol Med       Date:  2021-07-23       Impact factor: 0.804

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.